Liver Cancer
648
106
134
288
Key Insights
Highlights
Success Rate
83% trial completion
Published Results
88 trials with published results (14%)
Research Maturity
288 completed trials (44% of total)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
9.0%
58 terminated out of 648 trials
83.2%
-3.3% vs benchmark
9%
56 trials in Phase 3/4
31%
88 of 288 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 288 completed trials
Clinical Trials (648)
Collection of Blood From Patients With Cancer
Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors
Prospective Procurement of Tumor Tissue to Identify Novel Therapeutic Targets and Study the Tumor Microenvironment
Development and Testing of a Patient-facing Educational Tool About Liver Cancer Prevention
TRANScriptional Pathways Of Surgical Pain Modulated by Music Therapy Exposure (TRANSPOSE)
Distance-Based Exercise to Preserve Function and Prevent Disability
A Study to Test Different Doses of BI 765049 Alone and in Combination With Ezabenlimab in Asian People With Advanced Cancer (Solid Tumours) Positive for B7-H6
A Study to Test the Safety and Feasibility of Nivolumab With Drug Eluting Bead Transarterial Chemoembolization in Patients With Liver Cancer
Development of a Risk Prediction Model for Immune-Targeted Therapy-Related Diarrhea in Patients With Hepatocellular Carcinoma Based on TCM Constitutional Types: A Prospective Cohort Study
A Study of Nivolumab in Participants With Hepatocellular Carcinoma Who Are at High Risk of Recurrence After Curative Hepatic Resection or Ablation
Patient Controlled Epidural Analgesia Versus Intravenous Patient Controlled Analgesia for Post-Operative Pain Control in Patients Undergoing Elective Liver Resection
DESTINY-PANTUMOUR04
Patients With Hepatocellular Carcinoma (HCC)
DRAGON Registry - International Multicenter Registry and Medical Image Bank for Patients With Primarily Unresectable Liver Cancer or Liver Metastases That Underwent Combined Portal and Hepatic Vein Embolization (PVE/HVE) to Increase Future Liver Remnant Before Resection.
Unravelling the Impact of Radiofrecuency in Liver Surgery: the Key to Decrease Local Recurrence?
Pressure-enabled Delivery in Radioembolization (TriNav Study)
Jump: MR Simulation For Radiation Therapy Master Protocol
Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women
Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial
SL-28 for Advanced Solid Tumours